Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus
45%
CD4 Lymphocyte Count
24%
Viral Load
21%
Human Immunodeficiency Virus Infection
19%
Seroconversion
19%
Monospecific Antibody
18%
Blood Plasma
18%
Lymphocyte
15%
Peripheral Blood Mononuclear Cell
15%
CD4
13%
Western Blot
10%
Prevalence
10%
Antigen P24
9%
T Cell
9%
Macrophage
8%
Polymerase Chain Reaction
8%
High Risk Population
8%
Hepatitis B Antigen
7%
HBsAg
7%
Human T-Lymphotropic Virus 1
7%
Neutralizing Antibody
6%
Acquired Immune Deficiency Syndrome
6%
Viral Disease
5%
Enzyme Immunoassay
5%
Cell Culture
5%
Pneumocystis Carinii
5%
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
55%
Injection Drug Users
22%
AIDS/HIV
22%
Homosexual Men
19%
Seroconversion
14%
Peripheral Blood Mononuclear Cells
12%
CD4+
11%
HIV-1 Infection
10%
HIV Infection
9%
CD4 Count
9%
Disease Progression
9%
Viral Load
9%
HIV Viral Load
8%
Polymerase Chain Reaction
8%
P24 Antigen
7%
Human Immunodeficiency Virus Infection
7%
Virus
7%
COPDGene
6%
Western Blot
6%
Antigenemia
6%
Seroconverter
6%
Virus Load
6%
Macrophages
5%
Lymphocytes
5%
Cell-Associated
5%
Lymphocyte Count
5%
Pneumocystis Jirovecii
5%
Human Detection
5%
Intravenous Drug Users
5%
Medicine and Dentistry
Human Immunodeficiency Virus
40%
Human Immunodeficiency Virus 1
14%
Drug Administration
13%
Cell Count
12%
Infection
9%
Chronic Obstructive Pulmonary Disease
8%
Polymerase Chain Reaction
7%
Antigen P24
5%
Cohort Analysis
5%